Research at the Institute of Cell Biology and Immunology of the University of Stuttgart is dedicated to unravel the molecular mechanism of cell signaling and apoptosis, and the development of novel antibody-based reagents for tumor therapy and imaging. Our research concept is "discover - develop - deliver". Thus, an important aspect is the translation of results from cell biology, tumor biology, and systems biology into novel therapeutic concepts in the area of tumor therapy and treatment of inflammatory and neurodegenerative diseases. This includes predictive tools for cancer therapy and antibody-based therapeutic approaches and novel reagents for tumor imaging.